Skip to main content
Atrás
Watch Compare

ClearPoint Neuro, Inc.

Calidad de datos: 100%
CLPT
Nasdaq Manufacturing Measuring & Analyzing Instruments
$8.98
▼ $0.19 (-2.07%)
Cap. Mercado: 267.14 M
Precio
$8.98
Cap. Mercado
267.14 M
Rango del Día
$8.84 — $9.14
Rango de 52 Semanas
$8.60 — $30.10
Volumen
437,659
Apertura $9.06
Promedio 50D / 200D
$11.84
24.17% below
Promedio 50D / 200D
$14.16
36.57% below

Quick Summary

Puntos Clave

Revenue grew 22.72% annually over 5 years — strong growth
Negative free cash flow of -24.45 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 4.94%
Capital efficient — spends only 1.41% of revenue on capex

Crecimiento

Revenue Growth (5Y)
22.72%
Above sector avg (1.82%)
Revenue (1Y)17.78%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
-143.41%
Below sector avg (-53.47%)
ROIC-35.42%
Net Margin-69.08%
Op. Margin-65.36%

Seguridad

Debt / Equity
1.84
Above sector avg (0.31)
Current Ratio6.37
Interest Coverage-10.12

Valoración

PE (TTM)
-10.46
Below sector avg (-1.47)
P/B Ratio16.83
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (1364 pares)
Métrica Acción Mediana del Sector
P/E -10.5 -1.5
P/B 16.8 1.6
ROE % -143.4 -53.5
Net Margin % -69.1 -41.5
Rev Growth 5Y % 22.7 1.8
D/E 1.8 0.3

ETFs Holding This Stock

BRUSX BRUSX
0.79% weight
PSGIX PSGIX
0.02% weight
CSGEX CSGEX
0.02% weight
TMFX TMFX
0.02% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) 17.78% Revenue Growth (3Y) 24.23%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 22.72% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 36.97 M Net Income (TTM) -25.54 M
ROE -143.41% ROA -41.45%
Gross Margin 61.38% Operating Margin -65.36%
Net Margin -69.08% Free Cash Flow (TTM) -24.45 M
ROIC -35.42% FCF Growth (3Y) N/A
Safety
Debt / Equity 1.84 Current Ratio 6.37
Interest Coverage -10.12 Asset Turnover 0.60
Working Capital 43.28 M Tangible Book Value 15.87 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -10.46 Forward P/E N/A
P/B Ratio 16.83 P/S Ratio 7.23
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -9.15%
Market Cap 267.14 M Enterprise Value 258.12 M
Per Share
EPS (Diluted TTM) -0.90 Revenue / Share 1.24
FCF / Share -0.82 OCF / Share -0.80
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 1.41% FCF Conversion 95.72%
SBC-Adj. FCF -32.55 M Growth Momentum -4.94

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 36.97 M 31.39 M 23.96 M 20.55 M 16.30 M
Net Income -25.54 M -18.91 M -22.09 M -16.44 M -14.41 M
EPS (Diluted) -0.90 -0.70 -0.90 -0.68 —
Gross Profit 22.69 M 19.12 M 13.61 M 13.53 M 11.29 M
Operating Income -24.16 M -19.75 M -22.45 M -16.33 M -13.37 M
EBITDA — — — — —
R&D Expenses 13.90 M 12.39 M 11.71 M 10.89 M 8.99 M
SG&A Expenses 16.50 M 12.00 M 11.76 M 9.61 M 8.76 M
D&A 814,000.0 980,000.0 626,000.0 244,000.0 159,000.0
Interest Expense 2.39 M 872,000.0 386,000.0 81,000.0 973,000.0
Income Tax 55,000.0 12,000.0 8,000.0 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 97.75 M 39.19 M 42.66 M 55.49 M 65.58 M
Total Liabilities 69.73 M 13.80 M 21.49 M 18.60 M 16.79 M
Shareholders' Equity 28.02 M 25.39 M 21.17 M 36.89 M 48.79 M
Total Debt 49.08 M — 9.95 M 9.89 M 9.84 M
Cash & Equivalents 45.92 M 20.10 M 23.14 M 27.62 M 54.11 M
Current Assets 63.60 M 33.36 M 36.17 M 51.18 M 61.89 M
Current Liabilities 10.77 M 10.35 M 7.43 M 6.79 M 4.75 M